small-cap

Should You Sell Greencross Shares? GXL acquisition looks favourable

Dec 27, 2018 | Team Kalkine
Should You Sell Greencross Shares? GXL acquisition looks favourable

 

Greencross Limited

Attractive Acquisition with TPG inked by Board in the absence of superior proposal: Greencross Limited (ASX: GXL) is the largest specialist pet care business in Australia and New Zealand. The company aims to provide the customers with everything they need to ensure the health, happiness, and well-being of their pet. It has an extensive network retail store, veterinary clinics, grooming salons, and dog wash facilities across Australia and New Zealand. Recently, Greencross Limited has entered into a scheme implementation agreement with Vermont Australia, an entity owned by TPG capital to acquire 100% of Greencross shares in the absence of a superior proposal. The transaction price signifies multiple of ~10x FY2018A EV/EBITDA and 44.5% premium to the Greencross one-month volume weighted average. Under the terms of the scheme, GXL’s shareholders will be entitled to receive $5.55 per share, representing an attractive bid for the investors as it holds a higher premium at an aforesaid price.  It was advised that security holders should not take any action at this stage as the detail of scheme meeting is expected to be mailed to GXY’s shareholders in early Q1CY19. Further, the aforesaid scheme is likely to be implemented somewhere in 1HCY19, subject to the conditions of the scheme being satisfied.

Continuing with the financials, in FY2018, the group revenue grew by 7.5% to $878.7 million driven by network expansion and Group LFL sales growth of 4.9%. The online sales grew by 70% in FY 2018 and stood at $20 million, driven by click and collect business. Group gross margin increased by 90bps to 56.3% due to higher gross margin across all divisions. Underlying EBITDA, however, fell by 6% to $97.6 million and statutory NPAT attributable to Greencross shareholders decreased by 51% to $20.7 million as a result of $24.2 million of exceptional items. AS a result, ROE and pre-tax ROA came in at 4.3% and 3.4% in FY18 which is lower than the industry average of 12.6% and 10.9%. Moreover, current ratio stood at 1.13x in FY18 from the previous year of 1.30x, exhibiting degrowth of 13.2% in Y-O-Y basis. This has been under pressure over the past few years. The fundamental performance of the company seems to be weak for the past few years.
 

Expanding its Pet Care Model (Source: Company Reports)

However, the company is optimistic in delivering ongoing revenue growth and earnings growth in FY 2019 driven by the expansion of its proven business platform and delivery of the benefits of its integrated business model. The Group expects to deliver continued strong operating cash flows to support both acquisitive and organic growth in FY 2019.
Meanwhile, the share price has risen 42.22% in the past three months as at December 21, 2018 and trading at a higher PE multiple of 30.76x. Although the stock has yielded positive returns of 25.06% over the span of last six months, it may be driven by investor sentiments.  Hence, one needs to wait for the company’s results post-acquisition to find out the actual synergies from the acquisition with Vermont. Based on foregoing, we maintain our “Hold” recommendation on the stock at the current market price of $5.400.
 


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
 

Past performance is not a reliable indicator of future performance.